Drugs / anatrozole
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04836520 | Aug 2021 → Feb 2023 | breast cancer | Tianjin Medical University Cancer Institute and Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anatrozole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04836520 ↗ |